Lorquess (New Diet Pill)

Lorcaserin Hydrochloride (Arena)

An FDA advisory panel voted 18 to 4 in favor of the new weight loss drug Lorquess.

FDA Panel Gives Nod to New Diet Drug

By Emily P. Walker, Washington Correspondent, MedPage TodayPublished: May 10, 2012

SILVER SPRING, Md. -- An FDA advisory committee has voted 18-4, with one abstention, in favor of approving lorcaserin hydrochloride (Lorqess) as the first new weight-loss drug in more than a decade.

The FDA's Endocrinologic and Metabolic Drugs Advisory Committee on Thursday afternoon voted that the benefits of lorcaserin outweigh its risks, despite the modest weight loss provided by the drug and a lack of data to rule out heart valve issues. If approved, lorcaserin would be an option for those with a BMI of 30 or more, or a BMI of 27 with comorbidities related to obesity.

Read more about Lorquess.

Metabolic Medical Centers
Article on Lorquess